Stratec (ETR:SBS) Stock Price Down 4.2% – Here’s Why

Stratec SE (ETR:SBS)’s share price traded down 4.2% during trading on Friday . The company traded as low as €19.50 and last traded at €19.60. 27,883 shares were traded during trading, an increase of 346% from the average session volume of 6,253 shares. The stock had previously closed at €20.45.

Stratec Trading Down 4.2%

The company has a quick ratio of 1.65, a current ratio of 2.52 and a debt-to-equity ratio of 66.97. The stock has a 50-day moving average of €22.31 and a 200 day moving average of €24.72. The stock has a market cap of $235.47 million, a PE ratio of 23.52, a price-to-earnings-growth ratio of 10.43 and a beta of 0.16.

About Stratec

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.